Table 3 Exploratory multivariate linear regression assessing independent predictors of CAP reduction. R2 = 0.184, overall model p = 0.0107.

From: The early impact of bariatric surgery on metabolic dysfunction-associated steatotic liver disease (MASLD) as assessed by fibroscan at 6 months postoperatively

Predictor

β value

95% Confidence Interval

p value

TWL%

2.973

1.167–4.780

0.002

Age

0.281

-0.824–1.386

0.614

Sex (male)

14.775

-14.542–44.092

0.319

HTN (%)

1.903

-23.256–27.063

0.881

T2DM (%)

17.674

-14.687–50.035

0.280

OSA (%)

9.996

-14.810–34.802

0.425

  1. TWL% Total weight loss percentage; HTN hypertension; T2DM type 2 diabetes mellitus; OSA obstructive sleep apnoea